87 related articles for article (PubMed ID: 27330008)
1. Potential pitfalls associated with testing of enzyme preparations in the Salmonella/microsome assay.
Conti L; Crebelli R
Regul Toxicol Pharmacol; 2016 Oct; 80():291-4. PubMed ID: 27330008
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of metabolic activation of the promutagens, benzo[a]pyrene, 2-aminofluorene and 2-aminoanthracene by furanochromones in Salmonella typhimurium.
Schimmer O; Rauch P
Mutagenesis; 1998 Jul; 13(4):385-9. PubMed ID: 9717176
[TBL] [Abstract][Full Text] [Related]
3. Promutagen activation with mammalian and avian S9 liver microsomes.
Tometsko AM; Sheridan KM; DeTraglia MC
J Appl Toxicol; 1981 Feb; 1(1):11-4. PubMed ID: 6309943
[TBL] [Abstract][Full Text] [Related]
4. Comparative mutagenicity tests in the Salmonella/microsome assay with rat and woodchuck S9 preparations.
Rashid KA; Babish JG; Johnson BE; Mumma RO
Toxicology; 1985 Aug; 36(2-3):139-46. PubMed ID: 3931301
[TBL] [Abstract][Full Text] [Related]
5. Assay of phenacetin genotoxicity using in vitro and in vivo test systems.
De Flora S; Russo P; Pala M; Fassina G; Zunino A; Bennicelli C; Zanacchi P; Camoirano A; Parodi S
J Toxicol Environ Health; 1985; 16(3-4):355-77. PubMed ID: 3910846
[TBL] [Abstract][Full Text] [Related]
6. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
Kevekordes S; Porzig J; Gebel T; Dunkelberg H
Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
[TBL] [Abstract][Full Text] [Related]
7. Mixtures of polycyclic aromatic compounds inhibit mutagenesis in the Salmonella/microsome assay by inhibition of metabolic activation.
Haugen DA; Peak MJ
Mutat Res; 1983 Mar; 116(3-4):257-69. PubMed ID: 6300671
[TBL] [Abstract][Full Text] [Related]
8. Application of bacterial reverse mutation assay for detection of non-genotoxic carcinogens.
Kanode R; Chandra S; Sharma S
Toxicol Mech Methods; 2017 Jun; 27(5):376-381. PubMed ID: 28325086
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied.
Veres Z; Török G; Tóth E; Vereczkey L; Jemnitz K
Mutat Res; 2005 Sep; 586(1):18-27. PubMed ID: 16006184
[TBL] [Abstract][Full Text] [Related]
10. Effects of the hepatic S9 fraction from aroclor-1254-treated rats on the mutagenicity of benzo[alpha]pyrene and 2-aminoanthracene in the Salmonella/microsome assay.
Zeiger E; Chhabra RS; Margolin BH
Mutat Res; 1979 Dec; 64(6):379-89. PubMed ID: 118381
[TBL] [Abstract][Full Text] [Related]
11. Activation of benzo[a]pyrene and 2-aminoanthracene to bacteria mutagens by mussel digestive gland postmitochondrial fraction.
Michel XR; Cassand PM; Narbonne JF
Mutat Res; 1993 Feb; 301(2):113-9. PubMed ID: 7678168
[TBL] [Abstract][Full Text] [Related]
12. Rat nasal tissue activation of benzo(a)pyrene and 2-aminoanthracene to mutagens in Salmonella typhimurium.
Bond JA; Li AP
Environ Mutagen; 1983; 5(3):311-8. PubMed ID: 6303770
[TBL] [Abstract][Full Text] [Related]
13. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): IX. Evaluation of the mutagenic potential of synthesized L-valyl-L-prolyl-L-proline in the Salmonella-Escherichia coli/microsome, incorporation assay.
Bernard BK; Nakamura Y; Aihara K; Mennear JH
Int J Toxicol; 2005; 24 Suppl 4():107-13. PubMed ID: 16419582
[TBL] [Abstract][Full Text] [Related]
14. Optimization of a pre-metabolization procedure using rat liver S9 and cell-extracted S9 in the Ames fluctuation test.
Shao Y; Schiwy A; Glauch L; Henneberger L; König M; Mühlenbrink M; Xiao H; Thalmann B; Schlichting R; Hollert H; Escher BI
Sci Total Environ; 2020 Dec; 749():141468. PubMed ID: 32827816
[TBL] [Abstract][Full Text] [Related]
15. Study on the mutagenicity and antimutagenicity of beta-ionone in the Salmonella/microsome assay.
Gomes-Carneiro MR; Dias DM; Paumgartten FJ
Food Chem Toxicol; 2006 Apr; 44(4):522-7. PubMed ID: 16223554
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the relationship of metabolic activation system concentrations and chemical dose concentrations for the Salmonella spiral and plate assays.
Claxton LD; Houk VS; Allison JC; Creason J
Mutat Res; 1991 Oct; 253(2):127-36. PubMed ID: 1922139
[TBL] [Abstract][Full Text] [Related]
17. Use of Ames test in evaluation of shale oil fractions.
Pelroy RA; Petersen MR
Environ Health Perspect; 1979 Jun; 30():191-203. PubMed ID: 376309
[TBL] [Abstract][Full Text] [Related]
18. The metabolism of drugs and carcinogens in isolated subcellular fractions of Drosophila melanogaster. I. Activation of vinyl chloride, 2-aminoanthracene and benzo[a]pyrene as measured by mutagenic effects in Salmonella typhimurium.
Hällström I; Sundvall A; Rannug U; Grafström R; Ramel C
Chem Biol Interact; 1981 Mar; 34(2):129-43. PubMed ID: 6780204
[TBL] [Abstract][Full Text] [Related]
19. Mutagenicity testing of seminal fluid: seminal fluid increases the mutagenicity of the precursor mutagen benzo[a]pyrene in the presence of S9 mix.
Rivrud GN
Mutat Res; 1988 Jul; 208(3-4):195-200. PubMed ID: 3041272
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test.
Ayrton AD; Neville S; Ioannides C
Mutat Res; 1992 Jan; 265(1):1-8. PubMed ID: 1370238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
